APOE and Alzheimer disease: Apolipoprotein A-I (APOA-I) modulates AD occurrence and progression by binding to Aβ (Zuin et al., 2021), while the apolipoprotein E (APOE4) allele serves as a potential AD biomarker (Corder et al., 1993).